ZMC(600216)2021-04-22 16:00Financial Performance - Operating revenue for the period was CNY 2,399,934,853.19, representing a growth of 49.98% year-on-year[11] - Net profit attributable to shareholders was CNY 266,868,693.16, up 79.78% from the same period last year[11] - Basic earnings per share increased to CNY 0.28, an increase of 86.67% year-on-year[11] - The net profit after deducting non-recurring gains and losses was CNY 258,239,892.12, reflecting a significant increase of 157.89% year-on-year[11] - The company reported a net profit of CNY 4,858,657,393.81, up from CNY 4,535,485,577.05, representing an increase of approximately 7.1%[40] - Total operating revenue for Q1 2021 reached approximately 1.60 billion in Q1 2020[45] - Net profit for Q1 2021 was approximately 138.46 million in Q1 2020[47] - Total comprehensive income for the first quarter of 2021 was approximately CNY 323.17 million, compared to CNY 198.84 million in the same period of 2020, representing a year-over-year increase of 62.5%[53] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 10,950,209,798.47, an increase of 4.28% compared to the end of the previous year[11] - Total current assets amounted to CNY 5,351,705,315.93, compared to CNY 4,828,929,525.75, reflecting an increase of approximately 10.8%[39] - Total liabilities increased to CNY 2,248,486,021.77 from CNY 1,924,147,781.11, reflecting higher short-term borrowings[33] - Non-current assets totaled CNY 5,155,298,945.05, a slight increase from CNY 5,142,415,455.31, indicating a growth of about 0.3%[39] - The company’s total liabilities include short-term borrowings of 674,333,408.75[66] Cash Flow - The net cash flow from operating activities was CNY 40,674,099.24, a decrease of 76.70% compared to the previous year[11] - Cash received from tax refunds increased by 85.95% to ¥68,013,753.08, due to higher export tax rebates[23] - Cash flow from investment activities decreased by 42.47% to ¥168,264,972.62, due to reduced redemption of financial products[23] - Cash inflow from operating activities for the first quarter of 2021 was CNY 2.17 billion, compared to CNY 1.82 billion in the first quarter of 2020, indicating an increase of 19.4%[56] - Net cash flow from investing activities for the first quarter of 2021 was negative CNY 179.44 million, a decrease from a positive CNY 17.37 million in the first quarter of 2020[56] Shareholder Information - Total shareholders at the end of the reporting period reached 71,870, with the largest shareholder, New Changxing Investment Development Co., Ltd., holding 208,192,361 shares, representing 21.57%[17] - The total number of shares held by the top ten shareholders accounted for a significant portion of the company's equity, with the top two shareholders alone holding over 37%[17] Research and Development - Research and development expenses surged to 255,998,479.70, reflecting a 288.33% increase from 65,922,899.63 in the previous year, indicating a significant increase in R&D investment[20] - Research and development expenses surged to approximately 65.92 million in Q1 2020[45] Other Financial Metrics - The weighted average return on equity rose to 3.42%, an increase of 1.55 percentage points compared to the previous year[11] - The company reported a significant decrease in investment income, down 77.56% to 3,905,500.84, primarily due to the sale of part of its shares in Xianju Pharmaceutical in the previous year[20] - Income tax expenses increased by 66.31% to ¥53,711,098.55, attributed to higher total profit[23] - The company reported a significant increase in sales expenses, totaling approximately 292.70 million in Q1 2020[45]